These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 403834)

  • 21. Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.
    Ruiz J; Bertran S; Sauca G; Julià A; Vila X; Gómez E; Jiménez de Anta MT; Vila J
    Clin Microbiol Infect; 2005 Jan; 11(1):71-3. PubMed ID: 15649309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics of five oral cephalosporins in calves.
    Soback S; Ziv G; Kurtz B; Paz R
    Res Vet Sci; 1987 Sep; 43(2):166-72. PubMed ID: 3317582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of amikacin in the treatment of endometritis caused by Pseudomonas aeruginosa in mares].
    van Dyk E; Immelman A; van Heerden JS
    J S Afr Vet Assoc; 1982 Jun; 53(2):124-6. PubMed ID: 6811742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Rodríguez JR; Hernández NI; Ramírez-Ronda CH; Nevárez M
    Bol Asoc Med P R; 1985 Aug; 77(8):317-9. PubMed ID: 3931656
    [No Abstract]   [Full Text] [Related]  

  • 26. Escherichia coli infections in knee joints. The pharmacological and antibacterial effects of intramuscular antibiotics.
    Schurman DJ; Kajiyama G; Nagel DA
    J Bone Joint Surg Am; 1980; 62(4):620-7. PubMed ID: 6991503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli.
    Zinner SH; Provonchee RB; Elias KS; Peter G
    Antimicrob Agents Chemother; 1976 Apr; 9(4):661-4. PubMed ID: 817663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.
    Lagast H; Pascual-Lopez A; Dejace P; Klastersky J
    Eur J Clin Microbiol; 1986 Feb; 5(1):98-102. PubMed ID: 3084248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
    Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of combination of hetacillin, cephapirin and amikacin (author's transl)].
    Takahashi M; Ichiman Y; Usui Y; Narikawa S; Yoshida K
    Jpn J Antibiot; 1979 Aug; 32(8):830-8. PubMed ID: 114683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
    Van Laethem Y; Husson M; Klastersky J
    Antimicrob Agents Chemother; 1984 Aug; 26(2):224-7. PubMed ID: 6435515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacin.
    Hull R; Klinger JD; Moody EE
    J Gen Microbiol; 1976 Jun; 94(2):389-94. PubMed ID: 781182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.
    Parsley TL; Provonchee RB; Glicksman C; Zinner SH
    Antimicrob Agents Chemother; 1977 Sep; 12(3):349-52. PubMed ID: 410362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.
    Lagast H; Klastersky J; Standiford H; Viollier A
    Infection; 1984; 12(3):190-3. PubMed ID: 6432702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antibacterial activity of amikacin and ticarcillin, alone and in combination, against Pseudomonas aerurginosa.
    Yoshikawa TT; Shibata SA
    Antimicrob Agents Chemother; 1978 Jun; 13(6):997-9. PubMed ID: 98109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of amikacin and gentamicin.
    Klastersky J; Odio W; Hensgens C
    Clin Pharmacol Ther; 1975 Mar; 17(3):348-54. PubMed ID: 804370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglycoside antibiotics. IX. 1-N-acyl derivatives of kanamycin A (amikacin analogs).
    Naito T; Nakagawa S; Narita Y; Toda S; Abe Y
    J Antibiot (Tokyo); 1974 Nov; 27(11):851-8. PubMed ID: 4217789
    [No Abstract]   [Full Text] [Related]  

  • 38. Amikacin-induced alterations in the structure of gram-negative bacilli.
    Lorian V; Atkinson BA
    Diagn Microbiol Infect Dis; 1986 Jul; 5(2):93-7. PubMed ID: 3522089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological evaluation of amikacin in neonates.
    Howard JB; McCracken GH
    Antimicrob Agents Chemother; 1975 Jul; 8(1):86-90. PubMed ID: 1164009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacology of amikacin and kanamycin.
    Kirby WM; Clarke JT; Libke RD; Regamey C
    J Infect Dis; 1976 Nov; 134 SUPPL():S312-5. PubMed ID: 993624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.